LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction]
Wang K, Hu YB, Zhao Y, Ye C. Onco Targets Ther. 2021;14:565— 576. The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. It was bought to the journal’s attention that several figures within the article appea...
Main Authors: | Wang K, Hu YB, Zhao Y, Ye C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-03-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/retraction-lncrna-anril-regulates-ovarian-cancer-progression-and-tumo-peer-reviewed-article-OTT |
Similar Items
-
LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis
by: Wang K, et al.
Published: (2021-01-01) -
LncRNA ANRIL/miR-7-5p/TCF4 axis contributes to the progression of T cell acute lymphoblastic leukemia
by: Gang Li, et al.
Published: (2020-07-01) -
The lncRNA ANRIL is down-regulated in peripheral blood of patients with periodontitis
by: Leila Gholami, et al.
Published: (2020-06-01) -
ANRIL Genetic Variants in Iranian Breast Cancer Patients
by: Hamid Reza Khorshidi, et al.
Published: (2017-05-01) -
Downregulation of lncRNA ANRIL suppresses growth and metastasis in human osteosarcoma cells
by: Guan H, et al.
Published: (2018-08-01)